Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck. - Kim, Hye Ryun; Kang, Han Na; Yun, Mi Ran; Ju, Kwon Young; Choi, Jae Woo; Jung, Dong Min; Pyo, Kyoung Ho; Hong, Min Hee; Ahn, Myoung-Ju; Sun, Jong-Mu; Kim, Han Sang; Kim, Jinna; et al. (British Journal of Cancer, 2020)